Home
About Us
Company Profile
Enterprise culture
Qualification Honor
Chairman's Speech
Network
News
Company Dynamics
Industry dynamics
Recruitment
Contact Us
Contact Information
Online message
Nov 09,2023
Esomeprazole Magnesium Enteric-coated Dry Suspension Won the Bid for National Centralized Drug Procurement
Zhejiang Erying Pharmaceutical Co., Ltd., a holding subsidiary of Zhejiang Jianfeng Pharmaceutical Co., Ltd., participated in the bid for the ninth batch of national drug centralized procurement organized by the State Organization Drug Centralized Procurement and Use Joint Procurement Office. After the bid opening and evaluation by the joint procurement office, esomeprazole magnesium enteric-coated dry suspension (specification: 40mg) of Erying drug is proposed to win the bid for this centralized procurement.
Key words:
Feb 24,2023
Peak Pharmaceutical Won Many Honors in Tangxi Town
On the morning of February 10, Tangxi Town held a 2023 work conference to commend various advances in 2022. With its outstanding performance, Jianfeng Pharmaceutical Company won many honors such as "Enterprise with Tax Payment Excepting 10 Million Yuan", "Top Ten Industrial Enterprises" and "Advanced Enterprise in Safe Production" in 2022. It is the only pharmaceutical enterprise in Tangxi Town that combines three honors.
Feb 23,2023
Organize intellectual property knowledge training
On the afternoon of February 15, 2023, the pharmaceutical company hired intellectual property-related experts to conduct intellectual property knowledge training for relevant personnel.
Jianfeng Pharmaceutical Jindong District Leaders Visit After the Festival
On the afternoon of February 14, Ni Chunlei, a member of the Party Committee and Chief Engineer of the Jindong District Market Supervision Bureau, and his entourage visited Jinhua Pharmaceutical Company to have a discussion with members of the management team to learn more about the current operating conditions of the company, and asked pharmaceutical companies to seize the "post-epidemic era" Development opportunities, broaden the market, and create more benefits.
Aug 29,2012
Peak Pharmaceuticals was awarded the patent certificate of the invention of the slow-release tablets of aceclofenac and its preparation methods.
Peak pharmaceutical Xinjiang, Guangxi bidding success